In addition, the HDAC6 activity can affect the gene expression of some critical immune system molecules, including tumor-associated antigens, programmed death receptor-1 (PD-1), and programmed death receptor ligand-1 (PD-L1), which are central targets in cancer immunotherapy [20, 21]. The gene discussed is CD274; the disease is neoplasm.